Merck, Johnson & Johnson Share Gains Lead Dow's Nearly 50-point Climb

Dow Jones2022-09-23

DJ Merck, Johnson & Johnson Share Gains Lead Dow's Nearly 50-point Climb

This article was automatically generated by MarketWatch using technology from Automated Insights.

The Dow Jones Industrial Average is trading up Thursday afternoon with shares of Merck and Johnson & Johnson leading the way for the blue-chip average. Shares of Merck $(MRK)$ and Johnson & Johnson $(JNJ)$ have contributed to the index's intraday rally, as the Dow was most recently trading 47 points higher (0.2%). Merck's shares have risen $3.55 (4.2%) while those of Johnson & Johnson are up $3.80 (2.3%), combining for a roughly 48-point bump for the Dow. Other components contributing significantly to the gain include Amgen Inc. $(AMGN)$, Verizon Communications Inc. $(VZ)$, and Salesforce Inc. $(CRM)$. A $1 move in any one of the 30 components of the Dow equates to a 6.59-point swing.

Data source: Dow Jones Market Data, FactSet. Data compiled September 22, 2022.

(END) Dow Jones Newswires

September 22, 2022 15:03 ET (19:03 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment